OCATA THERAPEUTICS INC has a total of 34 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Hong Kong and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are REGENERTECH PTY LTD, REDBIOTEC AG and ARROWHEAD PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | Hong Kong | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Japan | 3 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Measurement | |
#6 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Lanza Robert P | 17 |
#2 | Klimanskaya Irina V | 10 |
#3 | Lu Shi-Jiang | 9 |
#4 | Lanza Robert | 6 |
#5 | Wang Wei | 5 |
#6 | Page Raymond | 3 |
#7 | Feng Qiang | 3 |
#8 | Chapman Karen | 3 |
#9 | Klimanskaya Irina | 3 |
#10 | Gay Roger | 3 |
Publication | Filing date | Title |
---|---|---|
AU2015252011A1 | Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy | |
US2016175362A1 | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells | |
CA2896053A1 | Methods for production of platelets from pluripotent stem cells and compositions thereof | |
AU2012205203A1 | Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |